The Promising Potency of Sodium–Glucose Cotransporter 2 Inhibitors in the Prevention of and as Treatment for Cognitive Impairment Among Type 2 Diabetes Patients

The Promising Potency of Sodium–Glucose Cotransporter 2 Inhibitors in the Prevention of and as Treatment for Cognitive Impairment Among Type 2 Diabetes Patients

Type 2 diabetes mellitus (T2DM), accounting for the majority of diabetes mellitus prevalence, is associated with an increased risk of cognition decline and deterioration of cognition function in diabetic patients. The sodium–glucose cotransporter 2 (SGLT2), located in the renal proximal tubule, play...

Full description

Saved in:
Bibliographic Details
Main Authors: Yibin Zhang, Xiaobin Liao, Jialu Xu, Jiaxin Yin, Shan Li, Mengni Li, Xiaoli Shi, Shujun Zhang, Chunyu Li, Weijie Xu, Xuefeng Yu, Yan Yang
Format: Article
Language:English
Published: MDPI AG 2024-12-01
Series:Biomedicines
Subjects:
type 2 diabetes mellitus (T2DM)
cognitive impairment (CI)
sodium–glucose cotransporter 2 inhibitors (SGLT2i)
mechanisms and pathways
clinical evidence
Online Access:https://www.mdpi.com/2227-9059/12/12/2783
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://www.mdpi.com/2227-9059/12/12/2783

Similar Items